🇺🇸 FDA
Pipeline program

Tissue Plasminogen Activator (Alteplase)

NTA0903

Phase 3 small_molecule completed

Quick answer

Tissue Plasminogen Activator (Alteplase) for Stroke is a Phase 3 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Stroke
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials